Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification

Pediatric Blood & Cancer, 05/04/2012

The authors describe a pediatric case of T–cell ALL with amplification of the ABL1 gene in which remission was achieved only after the addition of dasatinib to conventional chemotherapy.

Print Article Summary Cat 2 CME Report